RAD51 and cancer: Given the correlation of RAD51 overexpression with treatment resistance and an aggressive phenotype in many cancers, as well as the therapeutic potential of RAD51 inhibitors [59], subsequent studies on RAD51 genetic variants may yield clinically valuable results.